TENET HEALTHCARE CORP - Common Stock (THC)

CUSIP: 88033G407

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+45,369
SEC-reported price per share
$255.56
Number of holders
83
Value change
+$13,152,429
Number of buys
43
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
80,838,300

Security key

88033G407

Report period

Q3 2026

Institutions

83

Top holders

10

Ownership snapshot

Top reported holders of THC - TENET HEALTHCARE CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Aug 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 10%
PRICE T ROWE ASSOCIATES INC /MD/ 9.2%
VANGUARD CAPITAL MANAGEMENT LLC 5.3%
FMR LLC 4.6%
Invesco Ltd. 4.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
10%
$2,101,229,932
8,083,830 shares
-$79,975,522 31 Aug 2026
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
9.2%
$1,640,783,037
7,954,926 shares
$0 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5.3%
$864,671,673
4,582,013 shares
$0 31 Mar 2026
FMR LLC
13D/G 13F
Company
4.6%
$823,914,932
3,994,545 shares
$0 30 Jun 2026
Invesco Ltd.
13D/G 13F
Company
4.4%
$509,469,088
4,172,556 shares
$0 31 Mar 2025
Michael T. Maloney
3/4/5
EVP, Corporate Development
0.13%
$19,177,179
101,990 shares
— 27 Feb 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
83
Shares
520,590
Rows available
83
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
682
Q3 2026 holders
83
Holder diff
-599
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .